Healx3, an Accelerate Cambridge start-up, is hoping to find a cure for a six-year- old boy from US diagnosed with NGLY-1 deficiency. Healx3 is a medical technology startup which matches safe drugs to rare diseases. Tim Guilliams, CEO of the company, said there’s a hope for a cure:
Following further investigation of our identified marketed drugs, experimental validation will be the next key step.
Read the full article [businessweekly.co.uk]